Wen-Yang Liu, MD
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
2
2
0
N/A
0
0
Research Impact
N/A
Research impact score
0
Total publications
0
Published trial results
0
Total citations
Drug Portfolio
Analytics
Trial Phases
Trial Status
Role Distribution
Activity Timeline
Clinical Trials (2)
Research Network
Collaboration Network
Research Areas & Affiliations
Affiliations
Similar Key Opinion Leaders
Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.
Zhi-Hao Lu, MD
Peking University Cancer Hospital & Institute
Shared therapeutic areas:
Worked with same sponsors:
Lin Shen, MD
Peking University Cancer Hospital & Institute
Shared therapeutic areas:
Worked with same sponsors:
Lizhi Niu, PhD
Fuda Cancer Hospital
Shared therapeutic areas:
Christian Abnet, Ph.D.
National Cancer Institute (NCI)
Shared therapeutic areas:
Roberto P Benzo
Mayo Clinic
Shared therapeutic areas:
Jing Ren, Master
The First Affiliated Hospital of Henan University of Science and Technology
Shared therapeutic areas:
Worked with same sponsors:
Weijiao Yin, Master
The First Affiliated Hospital of Henan University of Science and Technology
Shared therapeutic areas:
Worked with same sponsors:
Wei Wang, Master
The First Affiliated Hospital of Henan University of Science and Technology
Shared therapeutic areas:
Worked with same sponsors:
Shegan Gao, Doctor
The First Affiliated Hospital of Henan University of Science and Technology
Shared therapeutic areas:
Worked with same sponsors:
Julian Abrams, MD
Columbia University
Shared therapeutic areas:
Publications (0)
No publications found for this investigator.
Clinical Trials (2)
Showing 2 of 2 trials
PD-1 Inhibitor Plus Chemotherapy With or Without Radiotherapy in Patients With Metastatic Esophageal Cancer
Radiotherapy in Patients With Metastatic Esophageal Cancer Responding to PD-1 Inhibitor Plus Chemotherapy
All 2 trials loaded